Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
13.1 EUR | -0.46% | -2.67% | +33.40% |
Sales 2024 * | 3.3M 3.59M | Sales 2025 * | 2.15M 2.34M | Capitalization | 828M 900M |
---|---|---|---|---|---|
Net income 2024 * | -159M -173M | Net income 2025 * | -173M -188M | EV / Sales 2024 * | 225 x |
Net cash position 2024 * | 87.4M 95.05M | Net cash position 2025 * | 44.68M 48.59M | EV / Sales 2025 * | 364 x |
P/E ratio 2024 * |
-4.77
x | P/E ratio 2025 * |
-4.66
x | Employees | 61 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.25% |
Latest transcript on Abivax
1 day | -0.46% | ||
1 week | -2.67% | ||
Current month | -11.25% | ||
1 month | -6.43% | ||
3 months | +16.34% | ||
6 months | +28.43% | ||
Current year | +33.40% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 66 | 23-05-04 | |
Didier Blondel
DFI | Director of Finance/CFO | - | 17-01-01 |
Sheldon Sloan
CTO | Chief Tech/Sci/R&D Officer | - | 23-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 65 | 13-12-03 | |
Kinam Hong
BRD | Director/Board Member | - | - |
Troy Ignelzi
BRD | Director/Board Member | 56 | 23-07-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 13.1 | -0.46% | 2 267 |
24-05-15 | 13.16 | -0.15% | 23,794 |
24-05-14 | 13.18 | +0.46% | 26,012 |
24-05-13 | 13.12 | -1.94% | 20,684 |
24-05-10 | 13.38 | -0.59% | 32,433 |
Real-time Euronext Paris, May 16, 2024 at 04:01 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.40% | 900M | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.56% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- ABVX Stock